Caprock Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.06M | Sell |
57,949
-23,019
| -28% | -$2.21M | 0.12% | 139 |
|
|
2025
Q4 | $7.84M | Buy |
80,968
+11,167
| +16% | +$1.08M | 0.17% | 99 |
|
|
2025
Q3 | $6.48M | Buy |
+69,801
| New | +$6.42M | 0.16% | 98 |
|
|
2025
Q1 | $6.05M | Buy |
66,839
+19,072
| +40% | +$1.71M | 0.18% | 93 |
|
|
2024
Q4 | $3.85M | Buy |
47,767
+5,363
| +13% | +$464K | 0.13% | 139 |
|
|
2024
Q3 | $3.85M | Buy |
42,404
+8,364
| +25% | +$704K | 0.14% | 126 |
|
|
2024
Q2 | $2.7M | Sell |
34,040
-8,953
| -21% | -$734K | 0.11% | 156 |
|
|
2024
Q1 | $3.78M | Sell |
42,993
-2,242
| -5% | -$191K | 0.22% | 67 |
|
|
2023
Q4 | $3.75M | Sell |
45,235
-4,008
| -8% | -$305K | 0.24% | 63 |
|
|
2023
Q3 | $3.89M | Buy |
49,243
+4,339
| +10% | +$363K | 0.29% | 55 |
|
|
2023
Q2 | $3.99M | Sell |
44,904
-212
| -0.5% | -$18.3K | 0.29% | 54 |
|
|
2023
Q1 | $3.67M | Buy |
45,116
+18,893
| +72% | +$1.54M | 0.28% | 56 |
|
|
2022
Q4 | $2.06M | Sell |
26,223
-6,702
| -20% | -$543K | 0.19% | 85 |
|
|
2022
Q3 | $2.68M | Buy |
32,925
+2,716
| +9% | +$244K | 0.26% | 56 |
|
|
2022
Q2 | $2.73M | Buy |
30,209
+2,337
| +8% | +$237K | 0.27% | 57 |
|
|
2022
Q1 | $3.11M | Buy |
27,872
+7,151
| +35% | +$755K | 0.29% | 58 |
|
|
2021
Q4 | $2.16M | Sell |
20,721
-3,076
| -13% | -$356K | 0.18% | 82 |
|
|
2021
Q3 | $3M | Buy |
23,797
+175
| +0.7% | +$22.6K | 0.27% | 56 |
|
|
2021
Q2 | $2.95M | Buy |
23,622
+50
| +0.2% | +$6.28K | 0.27% | 58 |
|
|
2021
Q1 | $2.8M | Buy |
23,572
+408
| +2% | +$47.8K | 0.31% | 54 |
|
|
2020
Q4 | $2.73M | Sell |
23,164
-98
| -0.4% | -$10.8K | 0.31% | 58 |
|
|
2020
Q3 | $2.43M | Buy |
23,262
+2,891
| +14% | +$290K | 0.33% | 51 |
|
|
2020
Q2 | $1.88M | Sell |
20,371
-158
| -0.8% | -$15.2K | 0.28% | 69 |
|
|
2020
Q1 | $1.86M | Buy |
20,529
+706
| +4% | +$75.1K | 0.35% | 55 |
|
|
2019
Q4 | $2.26M | Buy |
19,823
+467
| +2% | +$51.2K | 0.4% | 48 |
|
|
2019
Q3 | $2.11M | Sell |
19,356
-969
| -5% | -$101K | 0.41% | 46 |
|
|
2019
Q2 | $1.98M | Sell |
20,325
-487
| -2% | -$44.5K | 0.39% | 49 |
|
|
2019
Q1 | $1.91M | Buy |
20,812
+1,128
| +6% | +$101K | 0.37% | 53 |
|
|
2018
Q4 | $1.8M | Buy |
19,684
+162
| +0.8% | +$15.1K | 0.41% | 47 |
|
|
2018
Q3 | $1.93M | Sell |
19,522
-235
| -1% | -$21.7K | 0.39% | 46 |
|
|
2018
Q2 | $1.69M | Buy |
19,757
+1,054
| +6% | +$88K | 0.36% | 50 |
|
|
2018
Q1 | $1.51M | Buy |
18,703
+178
| +1% | +$14.7K | 0.32% | 58 |
|
|
2017
Q4 | $1.59M | Sell |
18,525
-665
| -3% | -$53.3K | 0.31% | 60 |
|
|
2017
Q3 | $1.5M | Buy |
19,190
+145
| +0.8% | +$12K | 0.31% | 61 |
|
|
2017
Q2 | $1.69M | Sell |
19,045
-512
| -3% | -$43.2K | 0.38% | 50 |
|
|
2017
Q1 | $1.58M | Sell |
19,557
-978
| -5% | -$76.4K | 0.37% | 48 |
|
|
2016
Q4 | $1.46M | Sell |
20,535
-1,232
| -6% | -$96.8K | 0.37% | 53 |
|
|
2016
Q3 | $1.88M | Buy |
21,767
+5,229
| +32% | +$456K | 0.43% | 53 |
|
|
2016
Q2 | $1.44M | Sell |
16,538
-484
| -3% | -$39.1K | 0.35% | 73 |
|
|
2016
Q1 | $1.28M | Buy |
+17,022
| New | +$1.28M | 0.3% | 72 |
|
Other funds holding MDT
VCM
VPM
Caprock Group's MDT Position: Q1 2026 in Review
Caprock Group reduced its Medtronic (MDT) stake by 28% in Q1 2026, selling an estimated $2.21M and leaving 57,949 shares worth $5.06M. The position accounts for 0.12% of the portfolio, ranked #139.
Caprock Group first reported a position in MDT in Q1 2016 and has held it in 40 quarters since. The position peaked at $7.84M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Caprock Group held 57,949 shares of Medtronic worth $5.06M as of Q1 2026.
- Caprock Group sold 23,019 Medtronic shares in Q1 2026, an estimated $2.21M.
- Medtronic made up 0.12% of Caprock Group's portfolio in Q1 2026, its #139 holding.
- Caprock Group first reported a position in Medtronic in Q1 2016 and has held it in 40 quarters since.
- Caprock Group's Medtronic position peaked at $7.84M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.